Pharmafile Logo
Pharmafocus logo
Advanced Search

LDL

Showing 5 posts of 5 posts found.

Pfizer image

Pfizer launches cardiovascular research competition

April 10, 2015
Research and Development, Sales and Marketing Amgen, Astellas, LDL, PCSK9, Pfizer, bococizumab, inhibitors

Pfizer is funding a new competitive grants programme to support research projects in the burgeoning, competitive area of cholesterol-lowering PCSK9 …

News
Amgen image

Success for Amgen’s ‘bad’ cholesterol injection

March 18, 2014
Research and Development, Sales and Marketing Amgen, LDL, PCSK9, evolocumab, hofh, tesla

An investigational PCSK9 Inhibitor from Amgen has reduced LDL-C (‘bad’ cholesterol) in patients suffering from a rare genetic disorder in …

News
Regeneron image

Phase III boost for alirocumab

October 17, 2013
Sales and Marketing LDL, Regeneron, alirocumab

Sanofi and Regeneron Pharmaceuticals are celebrating some upbeat data from their investigational treatment alirocumab, which has proved adept at tackling …

News

Blow for BioInvent as vascular treatment fails

July 11, 2012
Research and Development, Sales and Marketing BI-204, BioInvent, LDL, Sweden

Swedish biotech company BioInvent has suffered a new blow with the failure of its lead pipeline candidate.  The company’s share …

News
Amgen picture

Sanofi sets up cholesterol drug showdown with Amgen

March 27, 2012
Research and Development, Sales and Marketing Amgen, BMS, LDL, Lipitor, Merck, Regeneron, Sanofi

Sanofi and Amgen have posted results for their new injectable cholesterol drugs within 24 hours of each other.  Both drugs …

News

Latest content

Eli Lilly acquires new manufacturing facility from Nexus Pharmaceuticals

April 24, 2024

GSK’s Jemperli accepted for FDA review for endometrial cancer treatment

April 24, 2024

Sanofi shares results for phase 3 LUNA 3 trial in immune thrombocytopenia

April 23, 2024

FDA approves ImmunityBio’s Anktiva bladder cancer treatment

April 23, 2024

EC approves Pfizer’s Emblaveo for multidrug-resistant infection treatment

April 22, 2024